| GALDERMA GROUP SP.ADR/0,2 |
| USA |
| Gesundheit |
| US36321W1053 / A40C38 |
| PY30 (Frankfurt) |
| FRA:PY30, ETR:PY30, PY30:GR |
| - |
| https://www.galderma.com/ |
|
Galderma Group AG is a prominent player in the healthcare and dermatology sectors, renowned for its dedication to enhancing skin health. As a pharmaceutical company, it primarily focuses on research, development, and commercialization of dermatologic..
>Volltext.. |
| 39851.64 Mio. EUR |
| 41539.22 Mio. EUR |
| 4529.67 Mio. EUR |
| 1015.95 Mio. EUR |
| 532.33 Mio. EUR |
| 0.45 EUR |
| 2363.31 Mio. EUR |
| 281.55 Mio. EUR |
| 1025.33 Mio. EUR |
| 0.38 |
| 18.63% |
| 165.76% |
| - |
| 0.06% |
| 0.02% |
| - |
| GALDERMA ADR, GALDERMA |
| 04.04.26 |
|
||||
|
||||
|